新品储备与大促势能
Search documents
登康口腔(001328):Q3盈利稳健 费用投入阶段性缩减
Xin Lang Cai Jing· 2025-10-26 00:34
Core Insights - The company reported its Q3 2025 results, achieving a revenue of 1.23 billion yuan for the first three quarters, a year-on-year increase of 16.7%, and a net profit attributable to shareholders of 136 million yuan, up 15.2% year-on-year [1] - Q3 revenue was 386 million yuan, reflecting a year-on-year growth of 10.5%, while net profit attributable to shareholders was 51 million yuan, an increase of 11.4% year-on-year [1] - Revenue growth in Q3 showed signs of slowing down, attributed to a temporary reduction in e-commerce channel investments and a slowdown in e-commerce sales [1] Revenue and Profitability - The company achieved a gross margin of 50.5% for the first three quarters, an increase of 1.24 percentage points year-on-year, while the gross margin for Q3 was 45.9%, a decrease of 8 percentage points [2] - The sales expense ratio improved significantly in Q3, with a notable reduction due to the company's temporary cutback on e-commerce investments [2] - The net profit margin for the first three quarters was 11.06%, a slight decrease of 0.14 percentage points year-on-year, while the net profit margin for Q3 was 13.13%, an increase of 0.11 percentage points [2] Profit Forecast and Investment Recommendation - The company is projected to achieve net profits of 190 million yuan, 240 million yuan, and 290 million yuan for 2025-2027, with growth rates of 19.5%, 23.5%, and 23.2% respectively [3] - The current stock price corresponds to a PE ratio of 36X for 2025 and 29X for 2026, indicating potential growth driven by product channel upgrades and a solid pipeline of new products [3] - The company maintains a "buy" rating due to its strong brand value and growth potential [3]